Pemphigus foliaceus and pemphigus erythematosus

Christoph M. Hammers, Enno Schmidt*, Luca Borradori

*Corresponding author for this work

Abstract

Pemphigus foliaceus (PF) is a chronic autoimmune blistering disease of the skin, characterized by autoantibodies against a structural component of the epidermal desmosome, desmoglein 1 (Dsg1). Pemphigus erythematosus (PE; syn. Senear-Usher syndrome) is a localized form of PF with lesions typically developing on the face and the upper trunk and back. Management of pemphigus foliaceus does not greatly differ from that of pemphigus vulgaris. Systemic corticosteroids represent the mainstay of therapy and are usually combined with an immunosuppressive adjuvant.

Original languageEnglish
Title of host publicationEuropean Handbook of Dermatological Treatments, Third Edition
Number of pages10
PublisherSpringer Berlin Heidelberg
Publication date01.01.2015
Pages691-700
ISBN (Print)9783662451380
ISBN (Electronic)9783662451397
DOIs
Publication statusPublished - 01.01.2015

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Pemphigus foliaceus and pemphigus erythematosus'. Together they form a unique fingerprint.

Cite this